{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:39:43Z","timestamp":1792708783834,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scand J Trauma Resusc Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Remimazolam (RM) is a novel ultra-short acting benzodiazepine. This study evaluates the safety of using RM for procedural sedation in the emergency department (ED) comparing its administration by registered nurse anaesthetists versus house officers in 1st year residency in emergency medicine and emergency medicine physicians without previous anaesthesiologic specialisation. Secondary aims were patient satisfaction and proportion of successful procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This prospective study was performed at the ED at Aalborg University Hospital from 10 May through 20 August 2024. Five emergency medicine physicians (group 1) started administering RM to patients after completion of training and direct supervision. Results were compared to patients sedated by two registered nurse anaesthetists (group 2) who had been administering RM more than 50 times before study start. Time was recorded during sedation and a questionnaire filled out immediately after the patient had awakened. T-tests or Mann-Whitney U tests were used to compare groups. Proportions were calculated with chi-square (\u03c7<jats:sup>2<\/jats:sup>) tests of proportion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In group 1, 53 patients were sedated by emergency medicine physicians, and in group 2, 50 patients were sedated by registered nurse anaesthetists. No or mild respiratory adverse effects were observed in 97% of patients in group 1 versus 100% in group 2. Procedural amnesia was 93% in group 1 versus 90% in group 2. Patients were safe to be left unsupervised after a median of 15\u00a0min in both groups. Procedural success was 92% in group 1 versus 100% in group 2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Severe respiratory adverse effects after sedation were rare in both groups. Most patients had amnesia and adequate pain relief for the procedure. The use of RM by physicians without anaesthesiologic specialisation is considered a safe and effective alternative for procedural sedation in the ED.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>The study was registered and approved as a quality study (ID 2017\u2013011259) by the hospital administration.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13049-025-01402-6","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:06:10Z","timestamp":1747742770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Remimazolam for procedural sedation in the emergency department: a prospective study of effectiveness and patient satisfaction"],"prefix":"10.1186","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9911-5437","authenticated-orcid":false,"given":"Sofus","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-9612","authenticated-orcid":false,"given":"Vibe Maria Laden","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-7132","authenticated-orcid":false,"given":"Anne Lund","family":"Krarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M\u00f8ller","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Krogh-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-402X","authenticated-orcid":false,"given":"Dorte","family":"Melgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"1402_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/ACO.0000000000000487","volume":"30","author":"N Chawla","year":"2017","unstructured":"Chawla N, Boateng A, Deshpande R. Procedural sedation in the ICU and emergency department. Curr Opin Anaesthesiol. 2017;30:507\u201312. https:\/\/doi.org\/10.1097\/ACO.0000000000000487.","journal-title":"Curr Opin Anaesthesiol"},{"key":"1402_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.annemergmed.2013.10.015","volume":"63","author":"SA Godwin","year":"2014","unstructured":"Godwin SA, Burton JH, Gerardo CJ, et al. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014;63:247\u2013e5818. https:\/\/doi.org\/10.1016\/j.annemergmed.2013.10.015.","journal-title":"Ann Emerg Med"},{"key":"1402_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and Midazolam for moderate sedation during bronchoscopy. Chest. 2019;155:137\u201346. https:\/\/doi.org\/10.1016\/j.chest.2018.09.015.","journal-title":"Chest"},{"key":"1402_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and Midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88:427\u2013e4376. https:\/\/doi.org\/10.1016\/j.gie.2018.04.2351.","journal-title":"Gastrointest Endosc"},{"key":"1402_CR5","doi-asserted-by":"publisher","unstructured":"Matsuda Y, Karino M, Kanno T. Relationship between the functional oral intake scale (FOIS) and the Self-Efficacy scale among Cancer patients: A Cross-Sectional study. Healthc (Basel Switzerland). 2020;8. https:\/\/doi.org\/10.3390\/healthcare8030269.","DOI":"10.3390\/healthcare8030269"},{"key":"1402_CR6","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.clinthera.2022.09.014","volume":"44","author":"W Shi","year":"2022","unstructured":"Shi W, Cheng Y, He H, et al. Efficacy and safety of the Remimazolam-Alfentanil combination for sedation during gastroscopy: A randomized, Double-blind, Single-center controlled trial. Clin Ther. 2022;44:1506\u201318. https:\/\/doi.org\/10.1016\/j.clinthera.2022.09.014.","journal-title":"Clin Ther"},{"key":"1402_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/ACO.0000000000000652","volume":"31","author":"CRM Barends","year":"2018","unstructured":"Barends CRM, Absalom AR, Struys MMRF. Drug selection for ambulatory procedural sedation. Curr Opin Anaesthesiol. 2018;31:673\u20138. https:\/\/doi.org\/10.1097\/ACO.0000000000000652.","journal-title":"Curr Opin Anaesthesiol"},{"key":"1402_CR8","doi-asserted-by":"publisher","first-page":"e15495","DOI":"10.7717\/peerj.15495","volume":"11","author":"Y Chang","year":"2023","unstructured":"Chang Y, Huang Y-T, Chi K-Y, et al. Remimazolam versus Propofol for procedural sedation: a meta-analysis of randomized controlled trials. PeerJ. 2023;11:e15495. https:\/\/doi.org\/10.7717\/peerj.15495.","journal-title":"PeerJ"},{"key":"1402_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.23736\/S0375-9393.22.16631-9","volume":"88","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, et al. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiol. 2022;88:939\u201349. https:\/\/doi.org\/10.23736\/S0375-9393.22.16631-9.","journal-title":"Minerva Anestesiol"},{"key":"1402_CR10","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2147\/DDDT.S384155","volume":"16","author":"Q Hu","year":"2022","unstructured":"Hu Q, Liu X, Wen C, et al. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957\u201374. https:\/\/doi.org\/10.2147\/DDDT.S384155.","journal-title":"Drug Des Devel Ther"},{"key":"1402_CR11","unstructured":"M\u00f8ller JM. Sedation of patients using Remimazolam and Alfentanil in the emergency department. 2024.https:\/\/pri.rn.dk\/document\/AALBORGUH-905462050-26672 (accessed 6 Jan 2025)."},{"key":"1402_CR12","unstructured":"Ejstrud P, Aalborg UH. Sedation of patients with remimazolam without the involvement of anaesthetic personnel. 2023.https:\/\/pri.rn.dk\/Sider\/34629.aspx"},{"key":"1402_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf"},{"key":"1402_CR14","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inf"},{"key":"1402_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/emermed-2023-213805","volume":"41","author":"A van der Have","year":"2024","unstructured":"van der Have A, ten Harmsen BL, van Storm BW, et al. Remimazolam for procedural sedation: a future sedative potential in the emergency department? Emerg Med J. 2024;41:586\u20137. https:\/\/doi.org\/10.1136\/emermed-2023-213805.","journal-title":"Emerg Med J"},{"key":"1402_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/EJA.0000000000001715","volume":"39","author":"Y Yao","year":"2022","unstructured":"Yao Y, Guan J, Liu L, et al. Discharge readiness after remimazolam versus Propofol for colonoscopy: A randomised, double-blind trial. Eur J Anaesthesiol. 2022;39:911\u20137. https:\/\/doi.org\/10.1097\/EJA.0000000000001715.","journal-title":"Eur J Anaesthesiol"},{"key":"1402_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dld.2020.10.039","volume":"53","author":"DK Rex","year":"2021","unstructured":"Rex DK, Bhandari R, Lorch DG, et al. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Dig Liver Dis. 2021;53:94\u2013101. https:\/\/doi.org\/10.1016\/j.dld.2020.10.039.","journal-title":"Dig Liver Dis"},{"key":"1402_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12630-024-02697-2","volume":"71","author":"S Sancheti","year":"2024","unstructured":"Sancheti S, Uppal V. Is remimazolam the future of sedation for regional anesthesia? Can J Anaesth. 2024;71:731\u20136. https:\/\/doi.org\/10.1007\/s12630-024-02697-2.","journal-title":"Can J Anaesth"}],"container-title":["Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-025-01402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13049-025-01402-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-025-01402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:06:16Z","timestamp":1747742776000},"score":1,"resource":{"primary":{"URL":"https:\/\/sjtrem.biomedcentral.com\/articles\/10.1186\/s13049-025-01402-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1186\/s13049-025-01402-6","relation":{},"ISSN":["1757-7241"],"issn-type":[{"value":"1757-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered and approved as a quality study by the hospital administration (ID 2017\u2013011259) and the data safety regulations office (ID K2024-039). All patients consented orally to sedation with Remimazolam, and this was noted on their medical record. In Denmark, a quality study of a clinical treatment with an approved drug does not need written consent, only oral.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}